Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk
other	Headache	Nervous system disorders	Crinecerfont 50 mg	2	8
other	Arthropod sting	Injury, poisoning and procedural complications	Crinecerfont 50 mg	1	8
other	Blepharospasm	Eye disorders	Crinecerfont 50 mg	1	8
other	Dermatitis contact	Skin and subcutaneous tissue disorders	Crinecerfont 50 mg	1	8
other	Dizziness	Nervous system disorders	Crinecerfont 50 mg	1	8
other	Frequent bowel movements	Gastrointestinal disorders	Crinecerfont 50 mg	1	8
other	Gastritis	Gastrointestinal disorders	Crinecerfont 50 mg	1	8
other	Myalgia	Musculoskeletal and connective tissue disorders	Crinecerfont 50 mg	1	8
other	Nasopharyngitis	Infections and infestations	Crinecerfont 50 mg	1	8
other	Pyrexia	General disorders	Crinecerfont 50 mg	1	8
other	Vomiting	Gastrointestinal disorders	Crinecerfont 50 mg	1	8

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04045145/events